JP2020513032A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020513032A5 JP2020513032A5 JP2020502532A JP2020502532A JP2020513032A5 JP 2020513032 A5 JP2020513032 A5 JP 2020513032A5 JP 2020502532 A JP2020502532 A JP 2020502532A JP 2020502532 A JP2020502532 A JP 2020502532A JP 2020513032 A5 JP2020513032 A5 JP 2020513032A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- composition
- sequestering
- metabolite
- behavioral symptoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762480039P | 2017-03-31 | 2017-03-31 | |
| US62/480,039 | 2017-03-31 | ||
| PCT/US2018/025607 WO2018183986A1 (en) | 2017-03-31 | 2018-03-31 | Gut-selective sequestering agents for the treatment and prevention of autism and related disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020513032A JP2020513032A (ja) | 2020-04-30 |
| JP2020513032A5 true JP2020513032A5 (https=) | 2021-04-15 |
| JP6978122B2 JP6978122B2 (ja) | 2021-12-08 |
Family
ID=63677186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020502532A Expired - Fee Related JP6978122B2 (ja) | 2017-03-31 | 2018-03-31 | 自閉症および関連障害の治療および予防のための腸管選択的隔離剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US10617718B2 (https=) |
| EP (1) | EP3600349A4 (https=) |
| JP (1) | JP6978122B2 (https=) |
| KR (1) | KR102328323B1 (https=) |
| CN (2) | CN110944650B (https=) |
| AU (3) | AU2018243836B9 (https=) |
| BR (1) | BR112019020289A2 (https=) |
| CA (2) | CA3191747A1 (https=) |
| WO (1) | WO2018183986A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112019020289A2 (pt) | 2017-03-31 | 2020-09-01 | Axial Biotherapeutics, Inc. | agentes sequestrantes seletivos do intestino para o tratamento ou prevenção de autismo e distúrbios relacionados |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
| WO2021011481A1 (en) * | 2019-07-12 | 2021-01-21 | The General Hospital Corporation | Anti-inflammatory factors |
| CA3164484A1 (en) * | 2019-12-19 | 2021-06-24 | Hill's Pet Nutrition, Inc. | Compositions and methods of treating and reducing risk of conditions associated with elevated 4-ethylphenyl sulfate in canines using tomato pomace and methods of identifying canines at risk of such conditions |
| US20240197795A1 (en) * | 2020-07-27 | 2024-06-20 | Boadie DUNLOP | Assessment and treatment of depression, anxiety, or related disorders |
| CN113440522B (zh) * | 2021-07-29 | 2022-12-13 | 中山大学附属第七医院(深圳) | 一种吲哚丙酸在制备用于治疗自闭症药物中的应用 |
| CN115825314A (zh) * | 2021-09-17 | 2023-03-21 | 中国科学院深圳先进技术研究院 | 一种阿尔兹海默症生物标志物s-甲基-5′-硫代腺苷及其应用 |
| WO2023154547A1 (en) | 2022-02-14 | 2023-08-17 | Axial Therapeutics, Inc. | Colon targeted drug delivery |
| WO2023154966A1 (en) * | 2022-02-14 | 2023-08-17 | Axial Therapeutics, Inc. | Compositions and methods for sequestering metabolites in the gastrointestinal tract |
| CN116990395A (zh) * | 2022-04-26 | 2023-11-03 | 中国科学院深圳先进技术研究院 | 一种基于粪便的阿尔兹海默症生物标志物及其应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4761284A (en) | 1977-12-27 | 1988-08-02 | Kureha Kagaku Kogy Kabushiki Kaisha | Antidote including activated carbon particles |
| JPS5673542A (en) * | 1979-11-22 | 1981-06-18 | Kureha Chem Ind Co Ltd | Adsorbent |
| GB9611437D0 (en) | 1995-08-03 | 1996-08-07 | Secr Defence | Biomaterial |
| US7651974B2 (en) | 2002-11-01 | 2010-01-26 | Kureha Chemical Industry Co., Ltd. | Adsorbent for oral administration |
| JP2008523100A (ja) * | 2004-12-13 | 2008-07-03 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ５ｈｔ２ｃ受容体に関連した疾患の治療に有用な５ｈｔ２ｃ受容体のモジュレータとしてのｎ−ビアリール及びｎ−アリールヘテロアリール２−置換ピペラジン誘導体 |
| CA2754203A1 (en) * | 2009-03-05 | 2010-09-10 | Mithridion, Inc. | Compounds and compositions for cognition-enhancement, methods of making, and methods of treating |
| KR101593287B1 (ko) * | 2011-03-04 | 2016-02-11 | 가부시끼가이샤 구레하 | 정제형의 경구 투여용 조성물 및 그의 제조 방법 |
| US20140213534A1 (en) * | 2011-05-23 | 2014-07-31 | Thomas Jefferson University | Intestinal hyperpermeability and prevention of systemic disease |
| GB201204696D0 (en) * | 2012-03-16 | 2012-05-02 | Ucl Business Plc | Therapy |
| WO2014036182A2 (en) | 2012-08-29 | 2014-03-06 | California Institute Of Technology | Diagnosis and treatment of autism spectrum disorder |
| TWI520751B (zh) | 2013-02-22 | 2016-02-11 | 吳羽股份有限公司 | 經口投予用吸附劑及腎疾病治療劑及肝疾病治療劑 |
| MX2016000293A (es) | 2013-07-09 | 2016-06-21 | Stemina Biomarker Discovery Inc | Biomarcadores del trastrono del espectro autista. |
| US10071089B2 (en) * | 2013-07-23 | 2018-09-11 | Euro-Celtique S.A. | Combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation |
| US20150111878A1 (en) * | 2013-10-22 | 2015-04-23 | Steven Hoffman | Compositions and methods for treating intestinal hyperpermeability |
| US9763903B2 (en) * | 2013-10-22 | 2017-09-19 | Steven Hoffman | Compositions and methods for treating intestinal hyperpermeability |
| WO2015150590A1 (en) * | 2014-04-04 | 2015-10-08 | Biotechnobel Sa | Composition for prevention and/or treatment of chronic inflammation and concomitant biofilms in the gastrointestinal tract |
| BR112019020289A2 (pt) | 2017-03-31 | 2020-09-01 | Axial Biotherapeutics, Inc. | agentes sequestrantes seletivos do intestino para o tratamento ou prevenção de autismo e distúrbios relacionados |
-
2018
- 2018-03-31 BR BR112019020289-7A patent/BR112019020289A2/pt not_active Application Discontinuation
- 2018-03-31 WO PCT/US2018/025607 patent/WO2018183986A1/en not_active Ceased
- 2018-03-31 CN CN201880034095.5A patent/CN110944650B/zh not_active Expired - Fee Related
- 2018-03-31 KR KR1020197032302A patent/KR102328323B1/ko not_active Expired - Fee Related
- 2018-03-31 JP JP2020502532A patent/JP6978122B2/ja not_active Expired - Fee Related
- 2018-03-31 CA CA3191747A patent/CA3191747A1/en active Pending
- 2018-03-31 EP EP18778222.2A patent/EP3600349A4/en not_active Withdrawn
- 2018-03-31 CN CN202210138407.5A patent/CN114569633B/zh not_active Expired - Fee Related
- 2018-03-31 AU AU2018243836A patent/AU2018243836B9/en not_active Ceased
- 2018-03-31 CA CA3095724A patent/CA3095724C/en active Active
- 2018-05-31 US US15/994,571 patent/US10617718B2/en active Active
-
2020
- 2020-03-23 US US16/827,629 patent/US20200390809A1/en not_active Abandoned
- 2020-06-10 US US16/898,201 patent/US11007219B2/en not_active Expired - Fee Related
-
2021
- 2021-07-22 AU AU2021206871A patent/AU2021206871B2/en not_active Ceased
-
2022
- 2022-01-14 AU AU2022200220A patent/AU2022200220A1/en not_active Abandoned
-
2023
- 2023-06-30 US US18/345,279 patent/US20230364135A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020513032A5 (https=) | ||
| JP2018513107A5 (https=) | ||
| RU2010121827A (ru) | Композиции для лечения болезни паркинсона | |
| JP2021525729A5 (https=) | ||
| JP2016534153A5 (https=) | ||
| CN109310769A (zh) | 用rxr激动剂与甲状腺激素的组合的自身免疫疾病的治疗 | |
| WO2019235577A1 (ja) | 酸化ストレスに起因する疾患の予防又は治療剤 | |
| JP2020531543A (ja) | アマンタジン組成物、その調製、および使用方法 | |
| JP2018529747A5 (https=) | ||
| JP2019503335A (ja) | ジメチルアミノミケリオリドの使用 | |
| Mollica et al. | Obstructive sleep apnea and cardiovascular risks in the elderly population | |
| CN104161742A (zh) | 芬戈莫德及其结构类似物用于制备治疗脑出血药物的应用 | |
| CN102641350B (zh) | 温肺平喘颗粒及其制备工艺 | |
| Lemko et al. | The usage of haloaerosoltherapy in the rehabilitational treatment of children with reccurent bronchitis | |
| JP2020509036A5 (https=) | ||
| JP6719715B2 (ja) | 大腸ガンを治療或いは予防する医薬品 | |
| CN105362246B (zh) | 氨溴索沙丁胺醇控释片的制备方法 | |
| CN105456201B (zh) | 氨溴索沙丁胺醇微丸的制备方法 | |
| RU2278670C2 (ru) | Способ лечения бронхиальной астмы у детей в период ремиссии | |
| JP2021525796A (ja) | 神経疾患の阻害 | |
| RU2347576C1 (ru) | Средство для коррекции гиперреактивности дыхательных путей у детей | |
| CN105343040B (zh) | 氨溴索沙丁胺醇散剂的制备方法 | |
| CN105456221B (zh) | 氨溴索沙丁胺醇肠溶颗粒的制备方法 | |
| CN107281492B (zh) | 一种组合物的用途 | |
| CN110152003B (zh) | 一种用于治疗copd的复方药物及其制备方法 |